Gland Pharma (NSE:GLAND) Pre-Tax Income : ₹11,325 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gland Pharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Gland Pharma's pretax income for the three months ended in Mar. 2024 was ₹2,982 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹11,325 Mil. Gland Pharma's pretax margin was 19.40%.

During the past 7 years, Gland Pharma's highest Pretax Margin was 38.99%. The lowest was 19.99%. And the median was 34.43%.

Gland Pharma Pre-Tax Income Historical Data

The historical data trend for Gland Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gland Pharma Pre-Tax Income Chart

Gland Pharma Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Pre-Tax Income

Get a 7-Day Free Trial

9,928.66

13,348.10

16,185.52

10,545.82

11,325.42

Gland Pharma Quarterly Data
	Mar19	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															1,111.51	2,612.66	2,898.88	2,831.58	2,982.30

Competitive Comparison of Gland Pharma's Pre-Tax Income

For the Drug Manufacturers - General subindustry, Gland Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gland Pharma's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gland Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Gland Pharma's Pre-Tax Income falls into.

Gland Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Gland Pharma's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	9885.07	+	0	+	-262	+	0	+	1702.35
	=	11,325

Gland Pharma's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	2660.41	+	0	+	-99.58	+	0	+	421.47
	=	2,982

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹11,325 Mil.

Gland Pharma (NSE:GLAND) Pre-Tax Income Explanation

Gland Pharma's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	2982.3	/	15374.5
	=	19.40%

During the past 7 years, Gland Pharma's highest Pretax Margin was 38.99%. The lowest was 19.99%. And the median was 34.43%.

Gland Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Gland Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Gland Pharma (NSE:GLAND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gland Pharma Ltd (NSE:GLAND) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

543245:India

Address

Plot No. 11 and 84, TSIIC Phase: IV, Pashamylaram (V), Patancheru (M), Sangareddy District, Hyderabad, TG, IND, 502307

Website

https://www.glandpharma.com

Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Further, the group is involved in vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA.

Gland Pharma (NSE:GLAND) Headlines

No Headlines